ONCOLOGY
Through our smart genomic profiling tests and targeted clinical trial matching, Tempus informs treatment options for your patients at every point of their journey, transforming treatment over time.
COMPREHENSIVE GENOMIC PROFILING
We are able to identify genomic alterations through our germline and somatic testing options.
Our reports associate potentially relevant therapies with detected genomic alterations and prioritize them based on the strength of the clinical evidence.
- Tumor/normal match DNA sequencing
- Whole transcriptome RNA sequencing with validated fusion detection
- Automatic conversion option: Tempus|xT to Tempus|xF
- Concurrent and longitudinal testing options
- Structured clinical data integration
- Financial Assistance Program
-
Tempus|xT
Targeted panel of 648 genes
-
Tempus|xE
Whole exome of ~20,000 genes
-
Tempus|xF
Liquid biopsy panel of 105 genes
GETTING STARTED
How to order the Tempus sequencing test
We work directly with oncologists and pathologists to obtain normal and tumor samples. Once a physician and patient determine that Tempus testing is the right next step, the test can be ordered by the physician.
Our kits include everything needed for specimen collection, including easy-to-follow instructions, specimen guidelines, and packaging for convenient and fast shipping to our lab.
- Retrieve a Tempus blood or saliva collection kit. All required forms are contained in the box.
- Complete the requisition form. Physician and patient signatures are both required if sequencing both tumor and normal. Gather accompanying documents as noted on the form.
- Complete the financial assistance form with the patient.
- Fax the requisition form, financial assistance form, and accompanying documents to Tempus. Once the fax is received, we will request the tumor specimen from pathology.
- Retrieve a normal sample of blood or saliva from the patient, if required.
- Ship the normal sample using the enclosed clinical pack. Include faxed documents in the package.
Clinical decision support tools
Our real-time support tool connects physicians with up-to-date treatment options and relevant insights derived from real-world clinical evidence across millions of patients, our vast library of molecular profiling data, and our advanced analytics and machine-learning algorithms.
THE TEMPUS REPORT
In about two weeks, physicians receive a comprehensive report for each patient that highlights key findings, including actionable treatments, microsatellite instability (MSI) status, and tumor mutational burden (TMB) that can be immediately translated into cancer patient care.
Our reports are also embedded with Tempus Insights, patient-specific insights derived from real-world evidence to empower physicians with the necessary data to improve patient care.
Learn more about our additional testingThe Tempus Portal
Our portal allows physicians fast, reliable access to patient report status and results. View interactive and in-depth next-generation sequencing results in the context of a patient’s clinical history, filterable treatment applications and clinical trials, and PDFs of all Tempus reports.
Physicians will also have access to our real-time support tool offering deeper insight into the clinical report and access to additional research and analytics tools. These features and tools are also available in our mobile app.
Download the Tempus mobile app
PATIENT STORIES
CLINICAL TRIALS
We report open clinical trial matches that fit a patient’s molecular and phenotypic profiles.
Matched trials can be filtered by phase, geographic distance, and relevant inclusion and exclusion criteria to find the best option for each patient.
Tempus is changing the paradigm in clinical trial recruitment by ensuring that the right patients have access to the right trials at the right time through both our proprietary TIME Network and Connect referrals to existing sites.